AZ Maria Middelares | ClinicalTrials HQ

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.	Genital Diseases, Head and Neck Neoplasms, Male Urogenital Diseases, Neoplasms by Site, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, breast cancer, breast disorder, breast neoplasm, cancer, head and neck cancer, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder, skin disorder	Recruiting	Not stated	2026-09-15		NCT06970275
PRotEin Provision in Critical IllneSs -2	Critical Illness, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms	Not yet recruiting	Not applicable	2026-09-09		NCT07529522
Snapshot Study on Patients With Heart Failure	cardiovascular disorder, heart disorder, heart failure	Enrolling by invitation	Not stated	2026-08-20		NCT06469814
Registry for Patients Undergoing Penile Prosthesis Implantation for Male Erectile Dysfunction	Genital Diseases, Male Urogenital Diseases, Sexual Dysfunctions, Psychological, Urogenital Diseases, erectile dysfunction, male reproductive system disorder, physiological sexual disorder, psychiatric disorder	Active, not recruiting	Not stated	2026-06-16		NCT03849586
A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease	Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder	Recruiting	Not applicable	2026-06-01		NCT07363044
Adjuvant Palbociclib in Elderly Patients With Breast Cancer	Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder	Active, not recruiting	Phase 2	2026-05-12		NCT03609047
Stepwise Heat-Denaturated Protein Introduction for Tolerance Induction in Food Allergy	Cow's Milk Allergy, Hypersensitivity, Immediate, Milk Hypersensitivity, food allergy, immune system disorder	Recruiting	Not applicable	2026-05-08		NCT06380673
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease	Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder	Recruiting	Phase 2	2026-04-27		NCT06456593
Post-failure Stepwise Heat-Denaturated Protein Introduction for Tolerance Induction in Cow's Milk Allergy Observational Cohort Study	Cow's Milk Protein Allergy, Hypersensitivity, Immediate, Milk Hypersensitivity, food allergy, immune system disorder	Recruiting	Not stated	2026-03-04		NCT07448740
Proactive TDM Versus Standard Use of Biologics in Psoriasis	Psoriasis Vulgaris	Recruiting	Phase 4	2026-03-04		NCT06398106
FOLFIRINOX Versus OncoSil™ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic Adenocarcinoma	Locally Advanced Pancreatic Cancer	Active, not recruiting	Phase 2	2026-02-13		NCT05466799
A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC)	Metastatic Pancreatic Ductal Adenocarcinoma	Recruiting	Phase 2	2025-02-06		NCT05472259
PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases	Genital Diseases, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic malignant neoplasm, metastatic prostate carcinoma, neoplasm, prostate cancer, prostate disorder	Active, not recruiting	Phase 2	2024-12-09		NCT03569241
Long-term Better Than Short-term ADT With Salvage RT	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Recruiting	Phase 2 / Phase 3	2023-12-13		NCT04242017